Resorbable mesh in breast surgery

In Plastic Surgery Practice Mark Mofid express that he is positive about Resorbable mesh in breast surgery.

Extraction from article in Plastic Surgery Practice January 24, 2014:

... . .

Though he was among the first to present and publish on revisionary cosmetic breast surgery using acellular dermal matrix products, now he’s thinking differently about breast procedures and moving away from biologics due to the advent of non-tissue-based resorbable synthetic meshes or bioinductables, such as Allergan’s Seri scaffold, Novus Scientific’s Tigr Mesh, and Bard Davol’s Phasix Mesh. “The techniques in breast reconstruction and revisionary breast surgery have evolved far more rapidly than the products to support them. 

“Acellular dermal matrix, xenografts, allografts, and the like have higher rates of seroma and infection in most studies and are non-standardized in terms of thickness and revascularization,” he says. So far, there does not seem to be an increased risk of seroma with these new bioinductable meshes.

“The biologics are also more expensive to manufacture and need to be tracked. Some need to be kept refrigerated,” he says. By contrast, the resorbable synthetic meshes can be used for breast reconstruction and abdominal wall reinforcement after pedicle and free transverse rectus abdominus myocutaneous (TRAM) flaps, deep inferior epigastric perforators (DIEP) flaps, and for hernia repair. “They also have a role revisionary cosmetic breast surgery and to reinforce periareolar mastopexies.”

..... . .